hameln is represented in the strategically important markets of the international health market. Through our worldwide network of subsidiaries, joint ventures and distribution partnerships, we obtain approvals and market our own and third-party products.
Our injectable medicines are currently used in more than 40 countries worldwide. From Europe to the Middle East and Asia, to Africa and North and South America, doctors, pharmacists and nurses rely on our know-how and experience in the field of injectables.
Germany Learn More
Austria Learn More
United Kingdom Learn More
Europe Learn More
Asia & Pacific Learn More
Middle East & Africa Learn More
The Americas Learn More
hameln pharma gmbhInselstraße 1
CEO: Wolf-Christian Kanzelmeyer
Tel: +49 5151 581 576
Fax: +49 5151 581 501
hameln is a leading provider of high-quality generic injectable drugs that specialize in critical care. Our product portfolio includes an increasing number of products in various presentations including anesthetics, sedatives, analgesics and antidotes. Our products are used today in more than 40 countries worldwide. Doctors, pharmacists and nurses rely on our know-how and experience..